Cytek Biosciences
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $33,652 | $51,500 | $46,617 | $44,860 |
Gross Profit | 33,652 | 29,005 | 25,436 | 23,013 |
EBITDA | 7,239 | 3,083 | -4,572 | -6,092 |
EBIT | 4,390 | 274 | -7,052 | -8,552 |
Net Income | 9,643 | 941 | -10,434 | -6,169 |
Net Change In Cash | 33,652 | 51,500 | 46,617 | 44,860 |
Free Cash Flow | 1,094 | 12,413 | 5,003 | 3,335 |
Cash | 98,716 | 162,272 | 177,918 | 169,141 |
Basic Shares | 132,785 | 132,785 | 131,440 | 130,920 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $111,106 | $193,015 | $164,036 | $127,950 |
Gross Profit | 111,106 | 109,426 | 100,974 | 79,144 |
EBITDA | -20,523 | -4,407 | 9,535 | 10,399 |
EBIT | -13,637 | 3,833 | 9,157 | |
Net Income | -6,020 | -12,148 | 2,576 | 4,417 |
Net Change In Cash | 111,106 | 193,015 | 164,036 | 127,950 |
Cost of Revenue | -62,627 | 197,196 | ||
Free Cash Flow | 21,854 | 454 | -22,099 | 266 |
Cash | 98,716 | 167,299 | 296,601 | 364,618 |
Basic Shares | 132,785 | 135,283 | 138,562 | 133,749 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $0.11 |
2024-09-30 | $0.05 |
2024-06-30 | -$0.08 |
2024-03-31 | -$0.05 |
